Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in ...

University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically ...

Scientists found that a genetically engineered herpes simplex virus, when combined with immunotherapy, reduced or eliminated ...

Modified Herpes Virus as a Weapon Against Skin Cancer? A new study suggests it might work—even for metastases deep within the ...

The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...

Effectiveness against both herpes zoster and postherpetic neuralgia remained stable for at least 4 years after vaccination.

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

New imaging tools reveal how within an hour of infection, the virus begins to alter our chromosomes to kick-start its own replication.

This study has shown that HSV-1 is an "opportunistic interior designer" of human cells. | Genetics And Genomics ...

Could common viruses silently influence your brain health? Discover what new research reveals about herpes and dementia.